| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/29/2004 | WO2004034984A2 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 04/29/2004 | WO2004034982A2 Treatment termination in a medical device |
| 04/29/2004 | WO2004034980A2 Treatment for traumatic synovitis and damaged articular cartilage |
| 04/29/2004 | WO2004034975A2 Sustained release profile modification |
| 04/29/2004 | WO2004034973A2 Method of treating snoring and other obstructive breathing disorders |
| 04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
| 04/29/2004 | WO2004034971A2 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 04/29/2004 | WO2004034969A2 Functional sites |
| 04/29/2004 | WO2004034962A2 Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
| 04/29/2004 | WO2004034957A2 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004017914A3 Inhalation composition |
| 04/29/2004 | WO2004016101A3 Compositions comprising dietary fat complexer and methods for their use |
| 04/29/2004 | WO2003007986A8 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 04/29/2004 | WO2003000204A8 Multivalent mycoplasma bacterin |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | US20040082934 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 04/29/2004 | US20040082762 Humanized antibodies that recognize beta amyloid peptide |
| 04/29/2004 | US20040082540 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082514 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040081694 Melt-extruded orally administrable opioid formulations |
| 04/29/2004 | US20040081674 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins |
| 04/29/2004 | US20040081667 Compositions and methods for treating and preventing infection |
| 04/29/2004 | US20040081662 Vaccine |
| 04/29/2004 | US20040081626 Liquid mixture containing active materials; suspension drops in carrier gas; drug delivery; asthma therapy |
| 04/29/2004 | DE10248301A1 Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren Preparation of a live vaccine against influenza viruses |
| 04/29/2004 | CA2542620A1 Method of treating snoring and other obstructive breathing disorders |
| 04/29/2004 | CA2503325A1 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | CA2502787A1 Treating alcohol and or substance abuse by antagonizing .alpha. 2 adrenergic receptors with weak dopamine blocking |
| 04/29/2004 | CA2502510A1 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 04/29/2004 | CA2502397A1 Treatment for reactive arthritis or bursitis |
| 04/29/2004 | CA2502227A1 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 04/29/2004 | CA2502064A1 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 04/29/2004 | CA2501936A1 Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
| 04/29/2004 | CA2501298A1 Method of modifying the release profile of sustained release compositions |
| 04/29/2004 | CA2475053A1 Treatment of microbial infections and associated gastrointestinal disorders with thymosin .beta.4 |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1411918A2 Methods to mobilize progenitor/stem cells |
| 04/28/2004 | EP1083790B1 Retarding formulations of active substances used for plant protection |
| 04/28/2004 | EP0584068B2 Method and composition for ameliorating the adverse effects of aging |
| 04/28/2004 | EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1492758A Method and formula for anti-tumor and anti-matastatic effect |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1147305C Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
| 04/27/2004 | US6727276 Epothilone derivatives for the treatment of refractory tumors |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/22/2004 | WO2004032949A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/22/2004 | WO2004032882A2 Chemical compounds |
| 04/22/2004 | WO2004032880A2 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032876A2 Deguelin as a chemopreventive agent for lung cancer |
| 04/22/2004 | WO2004032873A2 Therapeutic combination of carnitine and antioxidant polyphenols |
| 04/22/2004 | WO2004032869A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 04/22/2004 | WO2004032867A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 04/22/2004 | WO2004032863A2 Oral formulations for proteins and polypeptides |
| 04/22/2004 | WO2004032861A2 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032851A2 Screening and therapeutic methods relating to neurogenesis |
| 04/22/2004 | WO2004032840A2 Compounds, compositions, and methods |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032831A2 Metalization of microtubules |
| 04/22/2004 | WO2004032830A2 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 04/22/2004 | WO2004032829A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 04/22/2004 | WO2004032823A2 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 04/22/2004 | WO2003096985A3 3d structure of the tsg101 uev domain |
| 04/22/2004 | WO2003063842A9 Composition for inhalation |
| 04/22/2004 | WO2003061561A8 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 04/22/2004 | WO2003051272A9 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2002098857A8 New indole derivatives with 5-ht6 receptor affinity |
| 04/22/2004 | US20040077948 Echogenic coatings with overcoat |
| 04/22/2004 | US20040077705 Cyclopentyl indole derivatives |
| 04/22/2004 | US20040077703 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040077554 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 04/22/2004 | US20040077551 NS3 protease inhibitors; quinoline derivatives |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | US20040076583 Method for indentification of biologically active agents |
| 04/22/2004 | CA2823937A1 Hiv vaccine formulations |
| 04/22/2004 | CA2531056A1 Therapeutic combination of carnitine and antioxidant polyphenols |
| 04/22/2004 | CA2501940A1 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 04/22/2004 | CA2501938A1 Compounds, compositions, and methods |
| 04/22/2004 | CA2501935A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/22/2004 | CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | CA2501476A1 Hiv vaccine formulations |
| 04/22/2004 | CA2501133A1 Oral formulations for proteins and polypeptides |
| 04/22/2004 | CA2500587A1 Screening and therapeutic methods relating to neurogenesis |
| 04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1408953A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/21/2004 | EP1408910A2 Stable cosmetic emulsion with polyamide gelling agent |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | EP0831766B1 Sunscreen compositions |